These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25254399)
1. [Spondyloarthritis including psoriatic arthritis]. Krause A; Märker-Hermann E Dtsch Med Wochenschr; 2014 Oct; 139(40):2017-9. PubMed ID: 25254399 [No Abstract] [Full Text] [Related]
2. Update on juvenile spondyloarthritis. Ramanathan A; Srinivasalu H; Colbert RA Rheum Dis Clin North Am; 2013 Nov; 39(4):767-88. PubMed ID: 24182854 [TBL] [Abstract][Full Text] [Related]
3. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study. Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209 [No Abstract] [Full Text] [Related]
4. The Seronegative Spondyloarthropathies. Duba AS; Mathew SD Prim Care; 2018 Jun; 45(2):271-287. PubMed ID: 29759124 [TBL] [Abstract][Full Text] [Related]
5. [Non-infective inflammations of the vertebral spine]. Peters KM Z Orthop Ihre Grenzgeb; 2007; 145(1):R1-19; quiz R20-4. PubMed ID: 17345531 [TBL] [Abstract][Full Text] [Related]
6. Imaging of the seronegative spondyloarthopathies. Amrami KK Radiol Clin North Am; 2012 Jul; 50(4):841-54. PubMed ID: 22643398 [TBL] [Abstract][Full Text] [Related]
7. Certolizumab pegol (Cimzia) and ustekinumab (Stelara) for psoriatic arthritis. Med Lett Drugs Ther; 2014 Feb; 56(1435):10-2. PubMed ID: 24662976 [No Abstract] [Full Text] [Related]
8. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings. Bonafede M; Fox KM; Watson C; Princic N; Gandra SR Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712 [TBL] [Abstract][Full Text] [Related]
9. [Clinical observations of a case of anterior uveitis associated with ankylosing spondylitis and psoriatic arthritis. Paraclinical studies]. Costescu I; Vîlciu A Oftalmologia; 1998; 42(2):74-7. PubMed ID: 9932362 [TBL] [Abstract][Full Text] [Related]
10. Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade. Paul S; Keat A Rheumatology (Oxford); 2005 Jan; 44(1):17-23. PubMed ID: 15328421 [No Abstract] [Full Text] [Related]
11. An approach to joint pain and inflammatory arthropathies. Glanville JR; Higgens C; Mouyis M Br J Hosp Med (Lond); 2016 Jul; 77(7):C109-11. PubMed ID: 27388393 [No Abstract] [Full Text] [Related]
12. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis. Kavanaugh A; Tutuncu Z; Catalan-Sanchez T Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453 [TBL] [Abstract][Full Text] [Related]
13. A case of rheumatoid arthritis with Felty syndrome complicated by late-onset ankylosing spondylitis and psoriatic arthritis: a potpourri of rheumatic diseases. Godhwani S; Gruber BL; Finzel K J Clin Rheumatol; 2015 Jan; 21(1):53-5. PubMed ID: 25539441 [No Abstract] [Full Text] [Related]
14. Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment? Dayer JM; Krane SM N Engl J Med; 2002 May; 346(18):1399-400. PubMed ID: 11986415 [No Abstract] [Full Text] [Related]
15. [Spondyloarthritis including psoriatic arthritis]. Rudwaleit M; Märker-Hermann E Dtsch Med Wochenschr; 2011 Oct; 136(40):2033-6. PubMed ID: 21960334 [No Abstract] [Full Text] [Related]
16. [Spondyloarthritis including psoriatic arthritis]. Krause A; Märker-Hermann E Dtsch Med Wochenschr; 2012 Oct; 137(40):2031-3. PubMed ID: 23023616 [No Abstract] [Full Text] [Related]
17. Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases. Khan MA Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S6-10. PubMed ID: 12463439 [TBL] [Abstract][Full Text] [Related]
18. New treatment paradigms in spondyloarthritis. van Mens LJJ; van de Sande MGH; Baeten DLP Curr Opin Rheumatol; 2018 Jan; 30(1):79-86. PubMed ID: 28984648 [TBL] [Abstract][Full Text] [Related]
19. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire. Barra L; Pope JE; Payne M J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267 [TBL] [Abstract][Full Text] [Related]
20. Do TNF-blockers reduce or induce uveitis? Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974 [No Abstract] [Full Text] [Related] [Next] [New Search]